Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:acquiredBy |
gptkb:Pfizer
|
gptkbp:acquisitionYear |
2022
|
gptkbp:focus |
immunology
cardiovascular diseases gastrointestinal diseases |
gptkbp:founded |
1997
|
gptkbp:founder |
gptkb:Jack_Lief
|
gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Arena Pharmaceuticals
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:notableProduct |
gptkb:Belviq
gptkb:Etrasimod gptkb:Ralinepag |
gptkbp:numberOfEmployees |
~200 (prior to acquisition)
|
gptkbp:status |
defunct (as of 2022, after acquisition)
|
gptkbp:tradedOn |
gptkb:Nasdaq:_ARNA
|
gptkbp:website |
https://www.arenapharm.com/
|
gptkbp:bfsParent |
gptkb:Pfizer
|
gptkbp:bfsLayer |
4
|